US recommendations fail to correct vitamin D deficiency

Vitamin D deficiency is widespread among women with breast cancer. Guidelines currently recommend daily supplementation with 400 IU vitamin D3; however, attainment of a circulating level of 25-hydroxyvitamin D defined as sufficient (that is, ≥75 nmol/l) might not be possible with this level of supplementation, according to data published in the Journal of Clinical Oncology.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Dose–response analysis of serum 25-hydroxyvitamin D levels after vitamin D3 supplementation.


  1. 1

    Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride 250–287 (National Academy Press, Washington, DC, 1997).

  2. 2

    Crew, K. D. et al. High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J. Clin. Oncol. 27, 2151–2156 (2009).

    CAS  Article  Google Scholar 

  3. 3

    Vieth, R., Chan, P. C. & MacFarlane, G. D. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am. J. Clin. Nutr. 73, 288–294 (2001).

    CAS  Article  Google Scholar 

  4. 4

    Hollis, B. W. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J. Nutr. 135, 317–322 (2005).

    CAS  Article  Google Scholar 

  5. 5

    Talwar, S. A., Aloia, J. F., Pollack, S. & Yeh, J. K. Dose response to vitamin D supplementation among postmenopausal African American women. Am. J. Clin. Nutr. 86, 1657–1662 (2007).

    CAS  Article  Google Scholar 

  6. 6

    Heaney, R. P., Davies, K. M., Chen, T. C., Holick, M. F. & Barger-Lux, M. J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 77, 204–210 (2003).

    CAS  Article  Google Scholar 

  7. 7

    Wactawski-Wende, J. et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med. 354, 684–696 (2006).

    CAS  Article  Google Scholar 

  8. 8

    Giovannucci, E. et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J. Natl Cancer Inst. 98, 451–459 (2006).

    CAS  Article  Google Scholar 

  9. 9

    Abbas, S. et al. Serum 25-hydroxyvitamin D and risk of postmenopausal breast cancer—results of a large case–control study. Carcinogenesis 29, 93–99 (2008).

    CAS  Article  Google Scholar 

  10. 10

    Lappe, J. M., Travers-Gustafson, D., Davies, K. M., Recker, R. R. & Heaney, R. P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 85, 1586–1591 (2007).

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Bruce W. Hollis.

Ethics declarations

Competing interests

Bruce W. Hollis is a consultant for DiaSorin.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hollis, B. US recommendations fail to correct vitamin D deficiency. Nat Rev Endocrinol 5, 534–536 (2009).

Download citation

Further reading